Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Novel Drug Delivery Systems Market 2018, Forecast to 2023
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
SCOPE OF THE REPORT:
This report focuses on the Novel Drug Delivery Systems in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of Novel Drug Delivery Systems includes Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, and the proportion of PEGylated Proteins & Polypeptides in 2017 is about 39.60%, and the proportion is in decreasing trend from 2013 to 2017.
North America is the largest consumption place, with a consumption market share nearly 49.69% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26.15%.
The worldwide market for Novel Drug Delivery Systems is expected to grow at a CAGR of roughly 2.2% over the next five years, will reach 30300 million US$ in 2023, from 26500 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Chapter 1, to describe Novel Drug Delivery Systems Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Novel Drug Delivery Systems, with sales, revenue, and price of Novel Drug Delivery Systems, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Novel Drug Delivery Systems, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Novel Drug Delivery Systems market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Novel Drug Delivery Systems sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Advantages of Novel Drug Delivery System are: Optimum dose at the right time and right location, efficient use of expensive drugs, excipients and reduction in production cost, Beneficial to patients, better therapy, improved comfort and standard of living.
SCOPE OF THE REPORT:
This report focuses on the Novel Drug Delivery Systems in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The classification of Novel Drug Delivery Systems includes Liposomes, PEGylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates, and the proportion of PEGylated Proteins & Polypeptides in 2017 is about 39.60%, and the proportion is in decreasing trend from 2013 to 2017.
North America is the largest consumption place, with a consumption market share nearly 49.69% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 26.15%.
The worldwide market for Novel Drug Delivery Systems is expected to grow at a CAGR of roughly 2.2% over the next five years, will reach 30300 million US$ in 2023, from 26500 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Amgen
- Teva
- UCB (Union Chimique Belge)
- Roche
- Celgene
- Sanofi
- Merck
- Johnson & Johnson
- Takeda
- Gilead Sciences
- Pfizer
- Dr Reddy
- Samyang Biopharmaceuticals
- TOLMAR
- Astellas
- AMAG Pharmaceuticals
- AstraZeneca
- AbbVie
- Bausch＆Lomb
- TWi Pharmaceuticals
- Novartis
- Aspen
- Shire
- Breckenridge Pharmaceuticals
- Galen
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- Liposomes
- PEGylated Proteins & Polypeptides
- Polymer Nanoparticle
- Protein–drug Conjugates
- Others
- Hospitals & Clinic
- Cancer Treatment Centers
- Others
Chapter 1, to describe Novel Drug Delivery Systems Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Novel Drug Delivery Systems, with sales, revenue, and price of Novel Drug Delivery Systems, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Novel Drug Delivery Systems, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Novel Drug Delivery Systems market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Novel Drug Delivery Systems sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW
1.1 Novel Drug Delivery Systems Introduction
1.2 Market Analysis by Type
1.2.1 Liposomes
1.2.2 PEGylated Proteins & Polypeptides
1.2.3 Polymer Nanoparticle
1.2.4 Protein–drug Conjugates
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals & Clinic
1.3.2 Cancer Treatment Centers
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Amgen
2.1.1 Business Overview
2.1.1.1 Amgen Description
2.1.1.2 Amgen Headquarter, Main Business and Finance Overview
2.1.2 Amgen Novel Drug Delivery Systems Product Introduction
2.1.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.1.2.2 Novel Drug Delivery Systems Product Information
2.1.3 Amgen Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Amgen Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Amgen Novel Drug Delivery Systems Market Share in 2017
2.2 Teva
2.2.1 Business Overview
2.2.1.1 Teva Description
2.2.1.2 Teva Headquarter, Main Business and Finance Overview
2.2.2 Teva Novel Drug Delivery Systems Product Introduction
2.2.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.2.2.2 Novel Drug Delivery Systems Product Information
2.2.3 Teva Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Teva Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Teva Novel Drug Delivery Systems Market Share in 2017
2.3 UCB (Union Chimique Belge)
2.3.1 Business Overview
2.3.1.1 UCB (Union Chimique Belge) Description
2.3.1.2 UCB (Union Chimique Belge) Headquarter, Main Business and Finance Overview
2.3.2 UCB (Union Chimique Belge) Novel Drug Delivery Systems Product Introduction
2.3.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.3.2.2 Novel Drug Delivery Systems Product Information
2.3.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 UCB (Union Chimique Belge) Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global UCB (Union Chimique Belge) Novel Drug Delivery Systems Market Share in 2017
2.4 Roche
2.4.1 Business Overview
2.4.1.1 Roche Description
2.4.1.2 Roche Headquarter, Main Business and Finance Overview
2.4.2 Roche Novel Drug Delivery Systems Product Introduction
2.4.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.4.2.2 Novel Drug Delivery Systems Product Information
2.4.3 Roche Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Roche Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Roche Novel Drug Delivery Systems Market Share in 2017
2.5 Celgene
2.5.1 Business Overview
2.5.1.1 Celgene Description
2.5.1.2 Celgene Headquarter, Main Business and Finance Overview
2.5.2 Celgene Novel Drug Delivery Systems Product Introduction
2.5.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.5.2.2 Novel Drug Delivery Systems Product Information
2.5.3 Celgene Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Celgene Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Celgene Novel Drug Delivery Systems Market Share in 2017
2.6 Sanofi
2.6.1 Business Overview
2.6.1.1 Sanofi Description
2.6.1.2 Sanofi Headquarter, Main Business and Finance Overview
2.6.2 Sanofi Novel Drug Delivery Systems Product Introduction
2.6.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.6.2.2 Novel Drug Delivery Systems Product Information
2.6.3 Sanofi Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Sanofi Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Sanofi Novel Drug Delivery Systems Market Share in 2017
2.7 Merck
2.7.1 Business Overview
2.7.1.1 Merck Description
2.7.1.2 Merck Headquarter, Main Business and Finance Overview
2.7.2 Merck Novel Drug Delivery Systems Product Introduction
2.7.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.7.2.2 Novel Drug Delivery Systems Product Information
2.7.3 Merck Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Merck Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Merck Novel Drug Delivery Systems Market Share in 2017
2.8 Johnson & Johnson
2.8.1 Business Overview
2.8.1.1 Johnson & Johnson Description
2.8.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.8.2 Johnson & Johnson Novel Drug Delivery Systems Product Introduction
2.8.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.8.2.2 Novel Drug Delivery Systems Product Information
2.8.3 Johnson & Johnson Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Johnson & Johnson Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Johnson & Johnson Novel Drug Delivery Systems Market Share in 2017
2.9 Takeda
2.9.1 Business Overview
2.9.1.1 Takeda Description
2.9.1.2 Takeda Headquarter, Main Business and Finance Overview
2.9.2 Takeda Novel Drug Delivery Systems Product Introduction
2.9.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.9.2.2 Novel Drug Delivery Systems Product Information
2.9.3 Takeda Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Takeda Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Takeda Novel Drug Delivery Systems Market Share in 2017
2.10 Gilead Sciences
2.10.1 Business Overview
2.10.1.1 Gilead Sciences Description
2.10.1.2 Gilead Sciences Headquarter, Main Business and Finance Overview
2.10.2 Gilead Sciences Novel Drug Delivery Systems Product Introduction
2.10.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.10.2.2 Novel Drug Delivery Systems Product Information
2.10.3 Gilead Sciences Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Gilead Sciences Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Gilead Sciences Novel Drug Delivery Systems Market Share in 2017
2.11 Pfizer
2.11.1 Business Overview
2.11.2 Pfizer Novel Drug Delivery Systems Product Introduction
2.11.3 Pfizer Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Dr Reddy
2.12.1 Business Overview
2.12.2 Dr Reddy Novel Drug Delivery Systems Product Introduction
2.12.3 Dr Reddy Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Samyang Biopharmaceuticals
2.13.1 Business Overview
2.13.2 Samyang Biopharmaceuticals Novel Drug Delivery Systems Product Introduction
2.13.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 TOLMAR
2.14.1 Business Overview
2.14.2 TOLMAR Novel Drug Delivery Systems Product Introduction
2.14.3 TOLMAR Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Astellas
2.15.1 Business Overview
2.15.2 Astellas Novel Drug Delivery Systems Product Introduction
2.15.3 Astellas Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 AMAG Pharmaceuticals
2.16.1 Business Overview
2.16.2 AMAG Pharmaceuticals Novel Drug Delivery Systems Product Introduction
2.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 AstraZeneca
2.17.1 Business Overview
2.17.2 AstraZeneca Novel Drug Delivery Systems Product Introduction
2.17.3 AstraZeneca Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 AbbVie
2.18.1 Business Overview
2.18.2 AbbVie Novel Drug Delivery Systems Product Introduction
2.18.3 AbbVie Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Bausch＆Lomb
2.19.1 Business Overview
2.19.2 Bausch＆Lomb Novel Drug Delivery Systems Product Introduction
2.19.3 Bausch＆Lomb Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 TWi Pharmaceuticals
2.20.1 Business Overview
2.20.2 TWi Pharmaceuticals Novel Drug Delivery Systems Product Introduction
2.20.3 TWi Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Novartis
2.21.1 Business Overview
2.21.2 Novartis Novel Drug Delivery Systems Product Introduction
2.21.3 Novartis Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 Aspen
2.22.1 Business Overview
2.22.2 Aspen Novel Drug Delivery Systems Product Introduction
2.22.3 Aspen Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.23 Shire
2.23.1 Business Overview
2.23.2 Shire Novel Drug Delivery Systems Product Introduction
2.23.3 Shire Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.24 Breckenridge Pharmaceuticals
2.24.1 Business Overview
2.24.2 Breckenridge Pharmaceuticals Novel Drug Delivery Systems Product Introduction
2.24.3 Breckenridge Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.25 Galen
2.25.1 Business Overview
2.25.2 Galen Novel Drug Delivery Systems Product Introduction
2.25.3 Galen Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET COMPETITION, BY MANUFACTURER
3.1 Global Novel Drug Delivery Systems Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Novel Drug Delivery Systems Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Novel Drug Delivery Systems Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Novel Drug Delivery Systems Manufacturer Market Share in 2017
3.4.2 Top 5 Novel Drug Delivery Systems Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET ANALYSIS BY REGIONS
4.1 Global Novel Drug Delivery Systems Sales, Revenue and Market Share by Regions
4.1.1 Global Novel Drug Delivery Systems Sales by Regions (2013-2018)
4.1.2 Global Novel Drug Delivery Systems Revenue by Regions (2013-2018)
4.2 North America Novel Drug Delivery Systems Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Novel Drug Delivery Systems Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Novel Drug Delivery Systems Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Novel Drug Delivery Systems Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Novel Drug Delivery Systems Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA NOVEL DRUG DELIVERY SYSTEMS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Novel Drug Delivery Systems Sales, Revenue and Market Share by Countries
5.1.1 North America Novel Drug Delivery Systems Sales by Countries (2013-2018)
5.1.2 North America Novel Drug Delivery Systems Revenue by Countries (2013-2018)
5.1.3 United States Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
5.1.4 Canada Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
5.1.5 Mexico Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
5.2 North America Novel Drug Delivery Systems Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Novel Drug Delivery Systems Sales by Manufacturers (2016-2017)
5.2.2 North America Novel Drug Delivery Systems Revenue by Manufacturers (2016-2017)
5.3 North America Novel Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Novel Drug Delivery Systems Sales and Sales Share by Type (2013-2018)
5.3.2 North America Novel Drug Delivery Systems Revenue and Revenue Share by Type (2013-2018)
5.4 North America Novel Drug Delivery Systems Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Novel Drug Delivery Systems Sales and Sales Share by Application (2013-2018)
5.4.2 North America Novel Drug Delivery Systems Revenue and Revenue Share by Application (2013-2018)
6 EUROPE NOVEL DRUG DELIVERY SYSTEMS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Novel Drug Delivery Systems Sales, Revenue and Market Share by Countries
6.1.1 Europe Novel Drug Delivery Systems Sales by Countries (2013-2018)
6.1.2 Europe Novel Drug Delivery Systems Revenue by Countries (2013-2018)
6.1.3 Germany Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.1.4 UK Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.1.5 France Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.1.6 Russia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.1.7 Italy Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.2 Europe Novel Drug Delivery Systems Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Novel Drug Delivery Systems Sales by Manufacturers (2016-2017)
6.2.2 Europe Novel Drug Delivery Systems Revenue by Manufacturers (2016-2017)
6.3 Europe Novel Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Novel Drug Delivery Systems Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Novel Drug Delivery Systems Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Novel Drug Delivery Systems Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Novel Drug Delivery Systems Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Novel Drug Delivery Systems Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Novel Drug Delivery Systems Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Novel Drug Delivery Systems Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Novel Drug Delivery Systems Revenue by Countries (2013-2018)
7.1.3 China Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.1.4 Japan Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.1.5 Korea Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.1.6 India Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Novel Drug Delivery Systems Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Novel Drug Delivery Systems Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Novel Drug Delivery Systems Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Novel Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Novel Drug Delivery Systems Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Novel Drug Delivery Systems Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Novel Drug Delivery Systems Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Novel Drug Delivery Systems Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Novel Drug Delivery Systems Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA NOVEL DRUG DELIVERY SYSTEMS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Novel Drug Delivery Systems Sales, Revenue and Market Share by Countries
8.1.1 South America Novel Drug Delivery Systems Sales by Countries (2013-2018)
8.1.2 South America Novel Drug Delivery Systems Revenue by Countries (2013-2018)
8.1.3 Brazil Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
8.1.4 Argentina Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
8.1.5 Colombia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
8.2 South America Novel Drug Delivery Systems Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Novel Drug Delivery Systems Sales by Manufacturers (2016-2017)
8.2.2 South America Novel Drug Delivery Systems Revenue by Manufacturers (2016-2017)
8.3 South America Novel Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Novel Drug Delivery Systems Sales and Sales Share by Type (2013-2018)
8.3.2 South America Novel Drug Delivery Systems Revenue and Revenue Share by Type (2013-2018)
8.4 South America Novel Drug Delivery Systems Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Novel Drug Delivery Systems Sales and Sales Share by Application (2013-2018)
8.4.2 South America Novel Drug Delivery Systems Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA NOVEL DRUG DELIVERY SYSTEMS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Novel Drug Delivery Systems Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Novel Drug Delivery Systems Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Novel Drug Delivery Systems Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.1.4 UAE Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.1.5 Egypt Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.1.7 South Africa Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Novel Drug Delivery Systems Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Novel Drug Delivery Systems Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Novel Drug Delivery Systems Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Novel Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Novel Drug Delivery Systems Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Novel Drug Delivery Systems Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Novel Drug Delivery Systems Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Novel Drug Delivery Systems Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Novel Drug Delivery Systems Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SEGMENT BY TYPE
10.1 Global Novel Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Novel Drug Delivery Systems Sales and Market Share by Type (2013-2018)
10.1.2 Global Novel Drug Delivery Systems Revenue and Market Share by Type (2013-2018)
10.2 Liposomes Sales Growth and Price
10.2.1 Global Liposomes Sales Growth (2013-2018)
10.2.2 Global Liposomes Price (2013-2018)
10.3 PEGylated Proteins & Polypeptides Sales Growth and Price
10.3.1 Global PEGylated Proteins & Polypeptides Sales Growth (2013-2018)
10.3.2 Global PEGylated Proteins & Polypeptides Price (2013-2018)
10.4 Polymer Nanoparticle Sales Growth and Price
10.4.1 Global Polymer Nanoparticle Sales Growth (2013-2018)
10.4.2 Global Polymer Nanoparticle Price (2013-2018)
10.5 Protein–drug Conjugates Sales Growth and Price
10.5.1 Global Protein–drug Conjugates Sales Growth (2013-2018)
10.5.2 Global Protein–drug Conjugates Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SEGMENT BY APPLICATION
11.1 Global Novel Drug Delivery Systems Sales Market Share by Application (2013-2018)
11.2 Hospitals & Clinic Sales Growth (2013-2018)
11.3 Cancer Treatment Centers Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 NOVEL DRUG DELIVERY SYSTEMS MARKET FORECAST (2018-2023)
12.1 Global Novel Drug Delivery Systems Sales, Revenue and Growth Rate (2018-2023)
12.2 Novel Drug Delivery Systems Market Forecast by Regions (2018-2023)
12.2.1 North America Novel Drug Delivery Systems Market Forecast (2018-2023)
12.2.2 Europe Novel Drug Delivery Systems Market Forecast (2018-2023)
12.2.3 Asia-Pacific Novel Drug Delivery Systems Market Forecast (2018-2023)
12.2.4 South America Novel Drug Delivery Systems Market Forecast (2018-2023)
12.2.5 Middle East and Africa Novel Drug Delivery Systems Market Forecast (2018-2023)
12.3 Novel Drug Delivery Systems Market Forecast by Type (2018-2023)
12.3.1 Global Novel Drug Delivery Systems Sales Forecast by Type (2018-2023)
12.3.2 Global Novel Drug Delivery Systems Market Share Forecast by Type (2018-2023)
12.4 Novel Drug Delivery Systems Market Forecast by Application (2018-2023)
12.4.1 Global Novel Drug Delivery Systems Sales Forecast by Application (2018-2023)
12.4.2 Global Novel Drug Delivery Systems Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
1.1 Novel Drug Delivery Systems Introduction
1.2 Market Analysis by Type
1.2.1 Liposomes
1.2.2 PEGylated Proteins & Polypeptides
1.2.3 Polymer Nanoparticle
1.2.4 Protein–drug Conjugates
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals & Clinic
1.3.2 Cancer Treatment Centers
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 MANUFACTURERS PROFILES
2.1 Amgen
2.1.1 Business Overview
2.1.1.1 Amgen Description
2.1.1.2 Amgen Headquarter, Main Business and Finance Overview
2.1.2 Amgen Novel Drug Delivery Systems Product Introduction
2.1.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.1.2.2 Novel Drug Delivery Systems Product Information
2.1.3 Amgen Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Amgen Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Amgen Novel Drug Delivery Systems Market Share in 2017
2.2 Teva
2.2.1 Business Overview
2.2.1.1 Teva Description
2.2.1.2 Teva Headquarter, Main Business and Finance Overview
2.2.2 Teva Novel Drug Delivery Systems Product Introduction
2.2.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.2.2.2 Novel Drug Delivery Systems Product Information
2.2.3 Teva Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Teva Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Teva Novel Drug Delivery Systems Market Share in 2017
2.3 UCB (Union Chimique Belge)
2.3.1 Business Overview
2.3.1.1 UCB (Union Chimique Belge) Description
2.3.1.2 UCB (Union Chimique Belge) Headquarter, Main Business and Finance Overview
2.3.2 UCB (Union Chimique Belge) Novel Drug Delivery Systems Product Introduction
2.3.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.3.2.2 Novel Drug Delivery Systems Product Information
2.3.3 UCB (Union Chimique Belge) Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 UCB (Union Chimique Belge) Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global UCB (Union Chimique Belge) Novel Drug Delivery Systems Market Share in 2017
2.4 Roche
2.4.1 Business Overview
2.4.1.1 Roche Description
2.4.1.2 Roche Headquarter, Main Business and Finance Overview
2.4.2 Roche Novel Drug Delivery Systems Product Introduction
2.4.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.4.2.2 Novel Drug Delivery Systems Product Information
2.4.3 Roche Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Roche Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Roche Novel Drug Delivery Systems Market Share in 2017
2.5 Celgene
2.5.1 Business Overview
2.5.1.1 Celgene Description
2.5.1.2 Celgene Headquarter, Main Business and Finance Overview
2.5.2 Celgene Novel Drug Delivery Systems Product Introduction
2.5.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.5.2.2 Novel Drug Delivery Systems Product Information
2.5.3 Celgene Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Celgene Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Celgene Novel Drug Delivery Systems Market Share in 2017
2.6 Sanofi
2.6.1 Business Overview
2.6.1.1 Sanofi Description
2.6.1.2 Sanofi Headquarter, Main Business and Finance Overview
2.6.2 Sanofi Novel Drug Delivery Systems Product Introduction
2.6.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.6.2.2 Novel Drug Delivery Systems Product Information
2.6.3 Sanofi Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Sanofi Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Sanofi Novel Drug Delivery Systems Market Share in 2017
2.7 Merck
2.7.1 Business Overview
2.7.1.1 Merck Description
2.7.1.2 Merck Headquarter, Main Business and Finance Overview
2.7.2 Merck Novel Drug Delivery Systems Product Introduction
2.7.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.7.2.2 Novel Drug Delivery Systems Product Information
2.7.3 Merck Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Merck Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Merck Novel Drug Delivery Systems Market Share in 2017
2.8 Johnson & Johnson
2.8.1 Business Overview
2.8.1.1 Johnson & Johnson Description
2.8.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.8.2 Johnson & Johnson Novel Drug Delivery Systems Product Introduction
2.8.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.8.2.2 Novel Drug Delivery Systems Product Information
2.8.3 Johnson & Johnson Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Johnson & Johnson Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Johnson & Johnson Novel Drug Delivery Systems Market Share in 2017
2.9 Takeda
2.9.1 Business Overview
2.9.1.1 Takeda Description
2.9.1.2 Takeda Headquarter, Main Business and Finance Overview
2.9.2 Takeda Novel Drug Delivery Systems Product Introduction
2.9.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.9.2.2 Novel Drug Delivery Systems Product Information
2.9.3 Takeda Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Takeda Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Takeda Novel Drug Delivery Systems Market Share in 2017
2.10 Gilead Sciences
2.10.1 Business Overview
2.10.1.1 Gilead Sciences Description
2.10.1.2 Gilead Sciences Headquarter, Main Business and Finance Overview
2.10.2 Gilead Sciences Novel Drug Delivery Systems Product Introduction
2.10.2.1 Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
2.10.2.2 Novel Drug Delivery Systems Product Information
2.10.3 Gilead Sciences Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Gilead Sciences Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Gilead Sciences Novel Drug Delivery Systems Market Share in 2017
2.11 Pfizer
2.11.1 Business Overview
2.11.2 Pfizer Novel Drug Delivery Systems Product Introduction
2.11.3 Pfizer Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Dr Reddy
2.12.1 Business Overview
2.12.2 Dr Reddy Novel Drug Delivery Systems Product Introduction
2.12.3 Dr Reddy Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Samyang Biopharmaceuticals
2.13.1 Business Overview
2.13.2 Samyang Biopharmaceuticals Novel Drug Delivery Systems Product Introduction
2.13.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 TOLMAR
2.14.1 Business Overview
2.14.2 TOLMAR Novel Drug Delivery Systems Product Introduction
2.14.3 TOLMAR Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Astellas
2.15.1 Business Overview
2.15.2 Astellas Novel Drug Delivery Systems Product Introduction
2.15.3 Astellas Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 AMAG Pharmaceuticals
2.16.1 Business Overview
2.16.2 AMAG Pharmaceuticals Novel Drug Delivery Systems Product Introduction
2.16.3 AMAG Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 AstraZeneca
2.17.1 Business Overview
2.17.2 AstraZeneca Novel Drug Delivery Systems Product Introduction
2.17.3 AstraZeneca Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 AbbVie
2.18.1 Business Overview
2.18.2 AbbVie Novel Drug Delivery Systems Product Introduction
2.18.3 AbbVie Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Bausch＆Lomb
2.19.1 Business Overview
2.19.2 Bausch＆Lomb Novel Drug Delivery Systems Product Introduction
2.19.3 Bausch＆Lomb Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 TWi Pharmaceuticals
2.20.1 Business Overview
2.20.2 TWi Pharmaceuticals Novel Drug Delivery Systems Product Introduction
2.20.3 TWi Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Novartis
2.21.1 Business Overview
2.21.2 Novartis Novel Drug Delivery Systems Product Introduction
2.21.3 Novartis Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 Aspen
2.22.1 Business Overview
2.22.2 Aspen Novel Drug Delivery Systems Product Introduction
2.22.3 Aspen Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.23 Shire
2.23.1 Business Overview
2.23.2 Shire Novel Drug Delivery Systems Product Introduction
2.23.3 Shire Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.24 Breckenridge Pharmaceuticals
2.24.1 Business Overview
2.24.2 Breckenridge Pharmaceuticals Novel Drug Delivery Systems Product Introduction
2.24.3 Breckenridge Pharmaceuticals Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.25 Galen
2.25.1 Business Overview
2.25.2 Galen Novel Drug Delivery Systems Product Introduction
2.25.3 Galen Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET COMPETITION, BY MANUFACTURER
3.1 Global Novel Drug Delivery Systems Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Novel Drug Delivery Systems Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Novel Drug Delivery Systems Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Novel Drug Delivery Systems Manufacturer Market Share in 2017
3.4.2 Top 5 Novel Drug Delivery Systems Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET ANALYSIS BY REGIONS
4.1 Global Novel Drug Delivery Systems Sales, Revenue and Market Share by Regions
4.1.1 Global Novel Drug Delivery Systems Sales by Regions (2013-2018)
4.1.2 Global Novel Drug Delivery Systems Revenue by Regions (2013-2018)
4.2 North America Novel Drug Delivery Systems Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Novel Drug Delivery Systems Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Novel Drug Delivery Systems Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Novel Drug Delivery Systems Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Novel Drug Delivery Systems Sales, Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA NOVEL DRUG DELIVERY SYSTEMS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
5.1 North America Novel Drug Delivery Systems Sales, Revenue and Market Share by Countries
5.1.1 North America Novel Drug Delivery Systems Sales by Countries (2013-2018)
5.1.2 North America Novel Drug Delivery Systems Revenue by Countries (2013-2018)
5.1.3 United States Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
5.1.4 Canada Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
5.1.5 Mexico Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
5.2 North America Novel Drug Delivery Systems Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Novel Drug Delivery Systems Sales by Manufacturers (2016-2017)
5.2.2 North America Novel Drug Delivery Systems Revenue by Manufacturers (2016-2017)
5.3 North America Novel Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Novel Drug Delivery Systems Sales and Sales Share by Type (2013-2018)
5.3.2 North America Novel Drug Delivery Systems Revenue and Revenue Share by Type (2013-2018)
5.4 North America Novel Drug Delivery Systems Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Novel Drug Delivery Systems Sales and Sales Share by Application (2013-2018)
5.4.2 North America Novel Drug Delivery Systems Revenue and Revenue Share by Application (2013-2018)
6 EUROPE NOVEL DRUG DELIVERY SYSTEMS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
6.1 Europe Novel Drug Delivery Systems Sales, Revenue and Market Share by Countries
6.1.1 Europe Novel Drug Delivery Systems Sales by Countries (2013-2018)
6.1.2 Europe Novel Drug Delivery Systems Revenue by Countries (2013-2018)
6.1.3 Germany Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.1.4 UK Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.1.5 France Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.1.6 Russia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.1.7 Italy Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.2 Europe Novel Drug Delivery Systems Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Novel Drug Delivery Systems Sales by Manufacturers (2016-2017)
6.2.2 Europe Novel Drug Delivery Systems Revenue by Manufacturers (2016-2017)
6.3 Europe Novel Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Novel Drug Delivery Systems Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Novel Drug Delivery Systems Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Novel Drug Delivery Systems Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Novel Drug Delivery Systems Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Novel Drug Delivery Systems Revenue and Revenue Share by Application (2013-2018)
7 ASIA-PACIFIC NOVEL DRUG DELIVERY SYSTEMS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
7.1 Asia-Pacific Novel Drug Delivery Systems Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Novel Drug Delivery Systems Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Novel Drug Delivery Systems Revenue by Countries (2013-2018)
7.1.3 China Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.1.4 Japan Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.1.5 Korea Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.1.6 India Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Novel Drug Delivery Systems Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Novel Drug Delivery Systems Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Novel Drug Delivery Systems Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Novel Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Novel Drug Delivery Systems Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Novel Drug Delivery Systems Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Novel Drug Delivery Systems Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Novel Drug Delivery Systems Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Novel Drug Delivery Systems Revenue and Revenue Share by Application (2013-2018)
8 SOUTH AMERICA NOVEL DRUG DELIVERY SYSTEMS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
8.1 South America Novel Drug Delivery Systems Sales, Revenue and Market Share by Countries
8.1.1 South America Novel Drug Delivery Systems Sales by Countries (2013-2018)
8.1.2 South America Novel Drug Delivery Systems Revenue by Countries (2013-2018)
8.1.3 Brazil Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
8.1.4 Argentina Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
8.1.5 Colombia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
8.2 South America Novel Drug Delivery Systems Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Novel Drug Delivery Systems Sales by Manufacturers (2016-2017)
8.2.2 South America Novel Drug Delivery Systems Revenue by Manufacturers (2016-2017)
8.3 South America Novel Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Novel Drug Delivery Systems Sales and Sales Share by Type (2013-2018)
8.3.2 South America Novel Drug Delivery Systems Revenue and Revenue Share by Type (2013-2018)
8.4 South America Novel Drug Delivery Systems Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Novel Drug Delivery Systems Sales and Sales Share by Application (2013-2018)
8.4.2 South America Novel Drug Delivery Systems Revenue and Revenue Share by Application (2013-2018)
9 MIDDLE EAST AND AFRICA NOVEL DRUG DELIVERY SYSTEMS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS
9.1 Middle East and Africa Novel Drug Delivery Systems Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Novel Drug Delivery Systems Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Novel Drug Delivery Systems Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.1.4 UAE Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.1.5 Egypt Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.1.7 South Africa Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Novel Drug Delivery Systems Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Novel Drug Delivery Systems Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Novel Drug Delivery Systems Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Novel Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Novel Drug Delivery Systems Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Novel Drug Delivery Systems Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Novel Drug Delivery Systems Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Novel Drug Delivery Systems Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Novel Drug Delivery Systems Revenue and Revenue Share by Application (2013-2018)
10 GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SEGMENT BY TYPE
10.1 Global Novel Drug Delivery Systems Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Novel Drug Delivery Systems Sales and Market Share by Type (2013-2018)
10.1.2 Global Novel Drug Delivery Systems Revenue and Market Share by Type (2013-2018)
10.2 Liposomes Sales Growth and Price
10.2.1 Global Liposomes Sales Growth (2013-2018)
10.2.2 Global Liposomes Price (2013-2018)
10.3 PEGylated Proteins & Polypeptides Sales Growth and Price
10.3.1 Global PEGylated Proteins & Polypeptides Sales Growth (2013-2018)
10.3.2 Global PEGylated Proteins & Polypeptides Price (2013-2018)
10.4 Polymer Nanoparticle Sales Growth and Price
10.4.1 Global Polymer Nanoparticle Sales Growth (2013-2018)
10.4.2 Global Polymer Nanoparticle Price (2013-2018)
10.5 Protein–drug Conjugates Sales Growth and Price
10.5.1 Global Protein–drug Conjugates Sales Growth (2013-2018)
10.5.2 Global Protein–drug Conjugates Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 GLOBAL NOVEL DRUG DELIVERY SYSTEMS MARKET SEGMENT BY APPLICATION
11.1 Global Novel Drug Delivery Systems Sales Market Share by Application (2013-2018)
11.2 Hospitals & Clinic Sales Growth (2013-2018)
11.3 Cancer Treatment Centers Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 NOVEL DRUG DELIVERY SYSTEMS MARKET FORECAST (2018-2023)
12.1 Global Novel Drug Delivery Systems Sales, Revenue and Growth Rate (2018-2023)
12.2 Novel Drug Delivery Systems Market Forecast by Regions (2018-2023)
12.2.1 North America Novel Drug Delivery Systems Market Forecast (2018-2023)
12.2.2 Europe Novel Drug Delivery Systems Market Forecast (2018-2023)
12.2.3 Asia-Pacific Novel Drug Delivery Systems Market Forecast (2018-2023)
12.2.4 South America Novel Drug Delivery Systems Market Forecast (2018-2023)
12.2.5 Middle East and Africa Novel Drug Delivery Systems Market Forecast (2018-2023)
12.3 Novel Drug Delivery Systems Market Forecast by Type (2018-2023)
12.3.1 Global Novel Drug Delivery Systems Sales Forecast by Type (2018-2023)
12.3.2 Global Novel Drug Delivery Systems Market Share Forecast by Type (2018-2023)
12.4 Novel Drug Delivery Systems Market Forecast by Application (2018-2023)
12.4.1 Global Novel Drug Delivery Systems Sales Forecast by Application (2018-2023)
12.4.2 Global Novel Drug Delivery Systems Market Share Forecast by Application (2018-2023)
13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 RESEARCH FINDINGS AND CONCLUSION
15 APPENDIX
15.1 Methodology
15.2 Data Source
LIST OF TABLES AND FIGURES
Figure Novel Drug Delivery Systems Picture
Table Product Specifications of Novel Drug Delivery Systems
Figure Global Novel Drug Delivery Systems CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Novel Drug Delivery Systems CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Novel Drug Delivery Systems by Types in 2017
Figure Liposomes Picture
Table Major Manufacturers of Liposomes
Figure PEGylated Proteins & Polypeptides Picture
Table Major Manufacturers of PEGylated Proteins & Polypeptides
Figure Polymer Nanoparticle Picture
Table Major Manufacturers of Polymer Nanoparticle
Figure Protein–drug Conjugates Picture
Table Major Manufacturers of Protein–drug Conjugates
Figure Others Picture
Table Major Manufacturers of Others
Figure Novel Drug Delivery Systems Sales Market Share by Applications in 2017
Figure Hospitals & Clinic Picture
Figure Cancer Treatment Centers Picture
Figure Others Picture
Figure United States Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure France Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure UK Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure China Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure India Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Table Amgen Headquarter, Established, Main Business and Finance Overview (2017)
Table Amgen Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Amgen Novel Drug Delivery Systems Product
Table Amgen Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amgen Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Amgen Novel Drug Delivery Systems Revenue Market Share in 2017
Table Teva Headquarter, Established, Main Business and Finance Overview (2017)
Table Teva Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Teva Novel Drug Delivery Systems Product
Table Teva Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Teva Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Teva Novel Drug Delivery Systems Revenue Market Share in 2017
Table UCB (Union Chimique Belge) Headquarter, Established, Main Business and Finance Overview (2017)
Table UCB (Union Chimique Belge) Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table UCB (Union Chimique Belge) Novel Drug Delivery Systems Product
Table UCB (Union Chimique Belge) Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global UCB (Union Chimique Belge) Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue Market Share in 2017
Table Roche Headquarter, Established, Main Business and Finance Overview (2017)
Table Roche Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Roche Novel Drug Delivery Systems Product
Table Roche Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Roche Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Roche Novel Drug Delivery Systems Revenue Market Share in 2017
Table Celgene Headquarter, Established, Main Business and Finance Overview (2017)
Table Celgene Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Celgene Novel Drug Delivery Systems Product
Table Celgene Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Celgene Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Celgene Novel Drug Delivery Systems Revenue Market Share in 2017
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Sanofi Novel Drug Delivery Systems Product
Table Sanofi Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Sanofi Novel Drug Delivery Systems Revenue Market Share in 2017
Table Merck Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Merck Novel Drug Delivery Systems Product
Table Merck Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Merck Novel Drug Delivery Systems Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Novel Drug Delivery Systems Product
Table Johnson & Johnson Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Johnson & Johnson Novel Drug Delivery Systems Revenue Market Share in 2017
Table Takeda Headquarter, Established, Main Business and Finance Overview (2017)
Table Takeda Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Takeda Novel Drug Delivery Systems Product
Table Takeda Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Takeda Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Takeda Novel Drug Delivery Systems Revenue Market Share in 2017
Table Gilead Sciences Headquarter, Established, Main Business and Finance Overview (2017)
Table Gilead Sciences Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Gilead Sciences Novel Drug Delivery Systems Product
Table Gilead Sciences Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Gilead Sciences Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Gilead Sciences Novel Drug Delivery Systems Revenue Market Share in 2017
Table Pfizer
Table Pfizer Novel Drug Delivery Systems
Table Dr Reddy
Table Dr Reddy Novel Drug Delivery Systems
Table Samyang Biopharmaceuticals
Table Samyang Biopharmaceuticals Novel Drug Delivery Systems
Table TOLMAR
Table TOLMAR Novel Drug Delivery Systems
Table Astellas
Table Astellas Novel Drug Delivery Systems
Table AMAG Pharmaceuticals
Table AMAG Pharmaceuticals Novel Drug Delivery Systems
Table AstraZeneca
Table AstraZeneca Novel Drug Delivery Systems
Table AbbVie
Table AbbVie Novel Drug Delivery Systems
Table Bausch＆Lomb
Table Bausch＆Lomb Novel Drug Delivery Systems
Table TWi Pharmaceuticals
Table TWi Pharmaceuticals Novel Drug Delivery Systems
Table Novartis
Table Novartis Novel Drug Delivery Systems
Table Aspen
Table Aspen Novel Drug Delivery Systems
Table Shire
Table Shire Novel Drug Delivery Systems
Table Breckenridge Pharmaceuticals
Table Breckenridge Pharmaceuticals Novel Drug Delivery Systems
Table Galen
Table Galen Novel Drug Delivery Systems
Table Global Novel Drug Delivery Systems Sales by Manufacturer (2016-2017)
Figure Global Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2016
Figure Global Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2017
Table Global Novel Drug Delivery Systems Revenue by Manufacturer (2016-2017)
Figure Global Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2016
Figure Global Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2017
Table Global Novel Drug Delivery Systems Price by Manufacturer (2016-2017)
Figure Top 3 Novel Drug Delivery Systems Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Novel Drug Delivery Systems Manufacturer (Revenue) Market Share in 2017
Figure Global Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Global Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table Global Novel Drug Delivery Systems Sales by Regions (2013-2018)
Table Global Novel Drug Delivery Systems Sales Market Share by Regions (2013-2018)
Table Global Novel Drug Delivery Systems Revenue by Regions (2013-2018)
Figure Global Novel Drug Delivery Systems Revenue Market Share by Regions in 2013
Figure Global Novel Drug Delivery Systems Revenue Market Share by Regions in 2017
Figure North America Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure North America Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Figure Europe Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Europe Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Figure South America Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure South America Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Figure North America Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table North America Novel Drug Delivery Systems Sales by Countries (2013-2018)
Table North America Novel Drug Delivery Systems Sales Market Share by Countries (2013-2018)
Figure North America Novel Drug Delivery Systems Sales Market Share by Countries in 2013
Figure North America Novel Drug Delivery Systems Sales Market Share by Countries in 2017
Table North America Novel Drug Delivery Systems Revenue by Countries (2013-2018)
Table North America Novel Drug Delivery Systems Revenue Market Share by Countries (2013-2018)
Figure North America Novel Drug Delivery Systems Revenue Market Share by Countries in 2013
Figure North America Novel Drug Delivery Systems Revenue Market Share by Countries in 2017
Figure United States Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Canada Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Mexico Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Table North America Novel Drug Delivery Systems Sales by Manufacturer (2016-2017)
Figure North America Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2016
Figure North America Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2017
Table North America Novel Drug Delivery Systems Revenue by Manufacturer (2016-2017)
Figure North America Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2016
Figure North America Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2017
Table North America Novel Drug Delivery Systems Sales by Type (2013-2018)
Table North America Novel Drug Delivery Systems Sales Share by Type (2013-2018)
Table North America Novel Drug Delivery Systems Revenue by Type (2013-2018)
Table North America Novel Drug Delivery Systems Revenue Share by Type (2013-2018)
Table North America Novel Drug Delivery Systems Sales by Application (2013-2018)
Table North America Novel Drug Delivery Systems Sales Share by Application (2013-2018)
Table North America Novel Drug Delivery Systems Revenue by Application (2013-2018)
Table North America Novel Drug Delivery Systems Revenue Share by Application (2013-2018)
Figure Europe Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table Europe Novel Drug Delivery Systems Sales by Countries (2013-2018)
Table Europe Novel Drug Delivery Systems Sales Market Share by Countries (2013-2018)
Table Europe Novel Drug Delivery Systems Revenue by Countries (2013-2018)
Figure Europe Novel Drug Delivery Systems Revenue Market Share by Countries in 2016
Figure Europe Novel Drug Delivery Systems Revenue Market Share by Countries in 2017
Figure Germany Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure UK Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure France Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Russia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Italy Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Table Europe Novel Drug Delivery Systems Sales by Manufacturer (2016-2017)
Figure Europe Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2016
Figure Europe Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2017
Table Europe Novel Drug Delivery Systems Revenue by Manufacturer (2016-2017)
Figure Europe Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2016
Figure Europe Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2017
Table Europe Novel Drug Delivery Systems Sales by Type (2013-2018)
Table Europe Novel Drug Delivery Systems Sales Share by Type (2013-2018)
Table Europe Novel Drug Delivery Systems Revenue by Type (2013-2018)
Table Europe Novel Drug Delivery Systems Revenue Share by Type (2013-2018)
Table Europe Novel Drug Delivery Systems Sales by Application (2013-2018)
Table Europe Novel Drug Delivery Systems Sales Share by Application (2013-2018)
Table Europe Novel Drug Delivery Systems Revenue by Application (2013-2018)
Table Europe Novel Drug Delivery Systems Revenue Share by Application (2013-2018)
Figure Asia-Pacific Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Sales by Countries (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Novel Drug Delivery Systems Sales Market Share by Countries 2017
Table Asia-Pacific Novel Drug Delivery Systems Revenue by Countries (2013-2018)
Figure Asia-Pacific Novel Drug Delivery Systems Revenue Market Share by Countries 2017
Figure China Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Japan Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Korea Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure India Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Southeast Asia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Novel Drug Delivery Systems Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Novel Drug Delivery Systems Sales by Type (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Sales Share by Type (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Revenue by Type (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Revenue Share by Type (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Sales by Application (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Sales Share by Application (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Revenue by Application (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Revenue Share by Application (2013-2018)
Figure South America Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table South America Novel Drug Delivery Systems Sales by Countries (2013-2018)
Table South America Novel Drug Delivery Systems Sales Market Share by Countries (2013-2018)
Figure South America Novel Drug Delivery Systems Sales Market Share by Countries in 2017
Table South America Novel Drug Delivery Systems Revenue by Countries (2013-2018)
Table South America Novel Drug Delivery Systems Revenue Market Share by Countries (2013-2018)
Figure South America Novel Drug Delivery Systems Revenue Market Share by Countries in 2017
Figure Brazil Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Argentina Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Colombia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Table South America Novel Drug Delivery Systems Sales by Manufacturer (2016-2017)
Figure South America Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2016
Figure South America Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2017
Table South America Novel Drug Delivery Systems Revenue by Manufacturer (2016-2017)
Figure South America Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2016
Figure South America Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2017
Table South America Novel Drug Delivery Systems Sales by Type (2013-2018)
Table South America Novel Drug Delivery Systems Sales Share by Type (2013-2018)
Table South America Novel Drug Delivery Systems Revenue by Type (2013-2018)
Table South America Novel Drug Delivery Systems Revenue Share by Type (2013-2018)
Table South America Novel Drug Delivery Systems Sales by Application (2013-2018)
Table South America Novel Drug Delivery Systems Sales Share by Application (2013-2018)
Table South America Novel Drug Delivery Systems Revenue by Application (2013-2018)
Table South America Novel Drug Delivery Systems Revenue Share by Application (2013-2018)
Figure Middle East and Africa Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Sales by Countries (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Novel Drug Delivery Systems Sales Market Share by Countries in 2017
Table Middle East and Africa Novel Drug Delivery Systems Revenue by Countries (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Countries in 2013
Figure Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Countries in 2017
Figure Saudi Arabia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure UAE Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Egypt Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Nigeria Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure South Africa Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Novel Drug Delivery Systems Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Novel Drug Delivery Systems Sales by Type (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Sales Share by Type (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Revenue by Type (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Revenue Share by Type (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Sales by Application (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Sales Share by Application (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Revenue by Application (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Revenue Share by Application (2013-2018)
Table Global Novel Drug Delivery Systems Sales by Type (2013-2018)
Table Global Novel Drug Delivery Systems Sales Share by Type (2013-2018)
Table Global Novel Drug Delivery Systems Revenue by Type (2013-2018)
Table Global Novel Drug Delivery Systems Revenue Share by Type (2013-2018)
Figure Global Liposomes Sales Growth (2013-2018)
Figure Global Liposomes Price (2013-2018)
Figure Global PEGylated Proteins & Polypeptides Sales Growth (2013-2018)
Figure Global PEGylated Proteins & Polypeptides Price (2013-2018)
Figure Global Polymer Nanoparticle Sales Growth (2013-2018)
Figure Global Polymer Nanoparticle Price (2013-2018)
Figure Global Protein–drug Conjugates Sales Growth (2013-2018)
Figure Global Protein–drug Conjugates Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Novel Drug Delivery Systems Sales by Application (2013-2018)
Table Global Novel Drug Delivery Systems Sales Share by Application (2013-2018)
Figure Global Hospitals & Clinic Sales Growth (2013-2018)
Figure Global Cancer Treatment Centers Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Novel Drug Delivery Systems Sales, Revenue and Growth Rate (2018-2023)
Table Global Novel Drug Delivery Systems Sales Forecast by Regions (2018-2023)
Table Global Novel Drug Delivery Systems Market Share Forecast by Regions (2018-2023)
Figure North America Sales Novel Drug Delivery Systems Market Forecast (2018-2023)
Figure Europe Sales Novel Drug Delivery Systems Market Forecast (2018-2023)
Figure Asia-Pacific Sales Novel Drug Delivery Systems Market Forecast (2018-2023)
Figure South America Sales Novel Drug Delivery Systems Market Forecast (2018-2023)
Figure Middle East and Africa Sales Novel Drug Delivery Systems Market Forecast (2018-2023)
Table Global Novel Drug Delivery Systems Sales Forecast by Type (2018-2023)
Table Global Novel Drug Delivery Systems Market Share Forecast by Type (2018-2023)
Table Global Novel Drug Delivery Systems Sales Forecast by Application (2018-2023)
Table Global Novel Drug Delivery Systems Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Figure Novel Drug Delivery Systems Picture
Table Product Specifications of Novel Drug Delivery Systems
Figure Global Novel Drug Delivery Systems CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Novel Drug Delivery Systems CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Novel Drug Delivery Systems by Types in 2017
Figure Liposomes Picture
Table Major Manufacturers of Liposomes
Figure PEGylated Proteins & Polypeptides Picture
Table Major Manufacturers of PEGylated Proteins & Polypeptides
Figure Polymer Nanoparticle Picture
Table Major Manufacturers of Polymer Nanoparticle
Figure Protein–drug Conjugates Picture
Table Major Manufacturers of Protein–drug Conjugates
Figure Others Picture
Table Major Manufacturers of Others
Figure Novel Drug Delivery Systems Sales Market Share by Applications in 2017
Figure Hospitals & Clinic Picture
Figure Cancer Treatment Centers Picture
Figure Others Picture
Figure United States Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure France Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure UK Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure China Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure India Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Novel Drug Delivery Systems Revenue (Value) and Growth Rate (2013-2023)
Table Amgen Headquarter, Established, Main Business and Finance Overview (2017)
Table Amgen Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Amgen Novel Drug Delivery Systems Product
Table Amgen Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amgen Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Amgen Novel Drug Delivery Systems Revenue Market Share in 2017
Table Teva Headquarter, Established, Main Business and Finance Overview (2017)
Table Teva Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Teva Novel Drug Delivery Systems Product
Table Teva Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Teva Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Teva Novel Drug Delivery Systems Revenue Market Share in 2017
Table UCB (Union Chimique Belge) Headquarter, Established, Main Business and Finance Overview (2017)
Table UCB (Union Chimique Belge) Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table UCB (Union Chimique Belge) Novel Drug Delivery Systems Product
Table UCB (Union Chimique Belge) Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global UCB (Union Chimique Belge) Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global UCB (Union Chimique Belge) Novel Drug Delivery Systems Revenue Market Share in 2017
Table Roche Headquarter, Established, Main Business and Finance Overview (2017)
Table Roche Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Roche Novel Drug Delivery Systems Product
Table Roche Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Roche Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Roche Novel Drug Delivery Systems Revenue Market Share in 2017
Table Celgene Headquarter, Established, Main Business and Finance Overview (2017)
Table Celgene Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Celgene Novel Drug Delivery Systems Product
Table Celgene Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Celgene Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Celgene Novel Drug Delivery Systems Revenue Market Share in 2017
Table Sanofi Headquarter, Established, Main Business and Finance Overview (2017)
Table Sanofi Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Sanofi Novel Drug Delivery Systems Product
Table Sanofi Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sanofi Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Sanofi Novel Drug Delivery Systems Revenue Market Share in 2017
Table Merck Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Merck Novel Drug Delivery Systems Product
Table Merck Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Merck Novel Drug Delivery Systems Revenue Market Share in 2017
Table Johnson & Johnson Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Novel Drug Delivery Systems Product
Table Johnson & Johnson Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Johnson & Johnson Novel Drug Delivery Systems Revenue Market Share in 2017
Table Takeda Headquarter, Established, Main Business and Finance Overview (2017)
Table Takeda Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Takeda Novel Drug Delivery Systems Product
Table Takeda Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Takeda Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Takeda Novel Drug Delivery Systems Revenue Market Share in 2017
Table Gilead Sciences Headquarter, Established, Main Business and Finance Overview (2017)
Table Gilead Sciences Novel Drug Delivery Systems Production Bases, Sales Regions and Major Competitors
Table Gilead Sciences Novel Drug Delivery Systems Product
Table Gilead Sciences Novel Drug Delivery Systems Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Gilead Sciences Novel Drug Delivery Systems Sales Market Share in 2017
Figure Global Gilead Sciences Novel Drug Delivery Systems Revenue Market Share in 2017
Table Pfizer
Table Pfizer Novel Drug Delivery Systems
Table Dr Reddy
Table Dr Reddy Novel Drug Delivery Systems
Table Samyang Biopharmaceuticals
Table Samyang Biopharmaceuticals Novel Drug Delivery Systems
Table TOLMAR
Table TOLMAR Novel Drug Delivery Systems
Table Astellas
Table Astellas Novel Drug Delivery Systems
Table AMAG Pharmaceuticals
Table AMAG Pharmaceuticals Novel Drug Delivery Systems
Table AstraZeneca
Table AstraZeneca Novel Drug Delivery Systems
Table AbbVie
Table AbbVie Novel Drug Delivery Systems
Table Bausch＆Lomb
Table Bausch＆Lomb Novel Drug Delivery Systems
Table TWi Pharmaceuticals
Table TWi Pharmaceuticals Novel Drug Delivery Systems
Table Novartis
Table Novartis Novel Drug Delivery Systems
Table Aspen
Table Aspen Novel Drug Delivery Systems
Table Shire
Table Shire Novel Drug Delivery Systems
Table Breckenridge Pharmaceuticals
Table Breckenridge Pharmaceuticals Novel Drug Delivery Systems
Table Galen
Table Galen Novel Drug Delivery Systems
Table Global Novel Drug Delivery Systems Sales by Manufacturer (2016-2017)
Figure Global Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2016
Figure Global Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2017
Table Global Novel Drug Delivery Systems Revenue by Manufacturer (2016-2017)
Figure Global Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2016
Figure Global Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2017
Table Global Novel Drug Delivery Systems Price by Manufacturer (2016-2017)
Figure Top 3 Novel Drug Delivery Systems Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Novel Drug Delivery Systems Manufacturer (Revenue) Market Share in 2017
Figure Global Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Global Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table Global Novel Drug Delivery Systems Sales by Regions (2013-2018)
Table Global Novel Drug Delivery Systems Sales Market Share by Regions (2013-2018)
Table Global Novel Drug Delivery Systems Revenue by Regions (2013-2018)
Figure Global Novel Drug Delivery Systems Revenue Market Share by Regions in 2013
Figure Global Novel Drug Delivery Systems Revenue Market Share by Regions in 2017
Figure North America Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure North America Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Figure Europe Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Europe Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Figure South America Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure South America Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Figure North America Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table North America Novel Drug Delivery Systems Sales by Countries (2013-2018)
Table North America Novel Drug Delivery Systems Sales Market Share by Countries (2013-2018)
Figure North America Novel Drug Delivery Systems Sales Market Share by Countries in 2013
Figure North America Novel Drug Delivery Systems Sales Market Share by Countries in 2017
Table North America Novel Drug Delivery Systems Revenue by Countries (2013-2018)
Table North America Novel Drug Delivery Systems Revenue Market Share by Countries (2013-2018)
Figure North America Novel Drug Delivery Systems Revenue Market Share by Countries in 2013
Figure North America Novel Drug Delivery Systems Revenue Market Share by Countries in 2017
Figure United States Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Canada Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Mexico Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Table North America Novel Drug Delivery Systems Sales by Manufacturer (2016-2017)
Figure North America Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2016
Figure North America Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2017
Table North America Novel Drug Delivery Systems Revenue by Manufacturer (2016-2017)
Figure North America Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2016
Figure North America Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2017
Table North America Novel Drug Delivery Systems Sales by Type (2013-2018)
Table North America Novel Drug Delivery Systems Sales Share by Type (2013-2018)
Table North America Novel Drug Delivery Systems Revenue by Type (2013-2018)
Table North America Novel Drug Delivery Systems Revenue Share by Type (2013-2018)
Table North America Novel Drug Delivery Systems Sales by Application (2013-2018)
Table North America Novel Drug Delivery Systems Sales Share by Application (2013-2018)
Table North America Novel Drug Delivery Systems Revenue by Application (2013-2018)
Table North America Novel Drug Delivery Systems Revenue Share by Application (2013-2018)
Figure Europe Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table Europe Novel Drug Delivery Systems Sales by Countries (2013-2018)
Table Europe Novel Drug Delivery Systems Sales Market Share by Countries (2013-2018)
Table Europe Novel Drug Delivery Systems Revenue by Countries (2013-2018)
Figure Europe Novel Drug Delivery Systems Revenue Market Share by Countries in 2016
Figure Europe Novel Drug Delivery Systems Revenue Market Share by Countries in 2017
Figure Germany Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure UK Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure France Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Russia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Italy Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Table Europe Novel Drug Delivery Systems Sales by Manufacturer (2016-2017)
Figure Europe Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2016
Figure Europe Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2017
Table Europe Novel Drug Delivery Systems Revenue by Manufacturer (2016-2017)
Figure Europe Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2016
Figure Europe Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2017
Table Europe Novel Drug Delivery Systems Sales by Type (2013-2018)
Table Europe Novel Drug Delivery Systems Sales Share by Type (2013-2018)
Table Europe Novel Drug Delivery Systems Revenue by Type (2013-2018)
Table Europe Novel Drug Delivery Systems Revenue Share by Type (2013-2018)
Table Europe Novel Drug Delivery Systems Sales by Application (2013-2018)
Table Europe Novel Drug Delivery Systems Sales Share by Application (2013-2018)
Table Europe Novel Drug Delivery Systems Revenue by Application (2013-2018)
Table Europe Novel Drug Delivery Systems Revenue Share by Application (2013-2018)
Figure Asia-Pacific Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Sales by Countries (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Novel Drug Delivery Systems Sales Market Share by Countries 2017
Table Asia-Pacific Novel Drug Delivery Systems Revenue by Countries (2013-2018)
Figure Asia-Pacific Novel Drug Delivery Systems Revenue Market Share by Countries 2017
Figure China Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Japan Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Korea Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure India Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Southeast Asia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Novel Drug Delivery Systems Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Novel Drug Delivery Systems Sales by Type (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Sales Share by Type (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Revenue by Type (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Revenue Share by Type (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Sales by Application (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Sales Share by Application (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Revenue by Application (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Revenue Share by Application (2013-2018)
Figure South America Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table South America Novel Drug Delivery Systems Sales by Countries (2013-2018)
Table South America Novel Drug Delivery Systems Sales Market Share by Countries (2013-2018)
Figure South America Novel Drug Delivery Systems Sales Market Share by Countries in 2017
Table South America Novel Drug Delivery Systems Revenue by Countries (2013-2018)
Table South America Novel Drug Delivery Systems Revenue Market Share by Countries (2013-2018)
Figure South America Novel Drug Delivery Systems Revenue Market Share by Countries in 2017
Figure Brazil Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Argentina Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Colombia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Table South America Novel Drug Delivery Systems Sales by Manufacturer (2016-2017)
Figure South America Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2016
Figure South America Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2017
Table South America Novel Drug Delivery Systems Revenue by Manufacturer (2016-2017)
Figure South America Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2016
Figure South America Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2017
Table South America Novel Drug Delivery Systems Sales by Type (2013-2018)
Table South America Novel Drug Delivery Systems Sales Share by Type (2013-2018)
Table South America Novel Drug Delivery Systems Revenue by Type (2013-2018)
Table South America Novel Drug Delivery Systems Revenue Share by Type (2013-2018)
Table South America Novel Drug Delivery Systems Sales by Application (2013-2018)
Table South America Novel Drug Delivery Systems Sales Share by Application (2013-2018)
Table South America Novel Drug Delivery Systems Revenue by Application (2013-2018)
Table South America Novel Drug Delivery Systems Revenue Share by Application (2013-2018)
Figure Middle East and Africa Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Sales by Countries (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Novel Drug Delivery Systems Sales Market Share by Countries in 2017
Table Middle East and Africa Novel Drug Delivery Systems Revenue by Countries (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Countries in 2013
Figure Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Countries in 2017
Figure Saudi Arabia Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure UAE Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Egypt Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure Nigeria Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Figure South Africa Novel Drug Delivery Systems Sales and Growth Rate (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Novel Drug Delivery Systems Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Novel Drug Delivery Systems Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Novel Drug Delivery Systems Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Novel Drug Delivery Systems Sales by Type (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Sales Share by Type (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Revenue by Type (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Revenue Share by Type (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Sales by Application (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Sales Share by Application (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Revenue by Application (2013-2018)
Table Middle East and Africa Novel Drug Delivery Systems Revenue Share by Application (2013-2018)
Table Global Novel Drug Delivery Systems Sales by Type (2013-2018)
Table Global Novel Drug Delivery Systems Sales Share by Type (2013-2018)
Table Global Novel Drug Delivery Systems Revenue by Type (2013-2018)
Table Global Novel Drug Delivery Systems Revenue Share by Type (2013-2018)
Figure Global Liposomes Sales Growth (2013-2018)
Figure Global Liposomes Price (2013-2018)
Figure Global PEGylated Proteins & Polypeptides Sales Growth (2013-2018)
Figure Global PEGylated Proteins & Polypeptides Price (2013-2018)
Figure Global Polymer Nanoparticle Sales Growth (2013-2018)
Figure Global Polymer Nanoparticle Price (2013-2018)
Figure Global Protein–drug Conjugates Sales Growth (2013-2018)
Figure Global Protein–drug Conjugates Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Novel Drug Delivery Systems Sales by Application (2013-2018)
Table Global Novel Drug Delivery Systems Sales Share by Application (2013-2018)
Figure Global Hospitals & Clinic Sales Growth (2013-2018)
Figure Global Cancer Treatment Centers Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Novel Drug Delivery Systems Sales, Revenue and Growth Rate (2018-2023)
Table Global Novel Drug Delivery Systems Sales Forecast by Regions (2018-2023)
Table Global Novel Drug Delivery Systems Market Share Forecast by Regions (2018-2023)
Figure North America Sales Novel Drug Delivery Systems Market Forecast (2018-2023)
Figure Europe Sales Novel Drug Delivery Systems Market Forecast (2018-2023)
Figure Asia-Pacific Sales Novel Drug Delivery Systems Market Forecast (2018-2023)
Figure South America Sales Novel Drug Delivery Systems Market Forecast (2018-2023)
Figure Middle East and Africa Sales Novel Drug Delivery Systems Market Forecast (2018-2023)
Table Global Novel Drug Delivery Systems Sales Forecast by Type (2018-2023)
Table Global Novel Drug Delivery Systems Market Share Forecast by Type (2018-2023)
Table Global Novel Drug Delivery Systems Sales Forecast by Application (2018-2023)
Table Global Novel Drug Delivery Systems Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
